In conclusion, these findings suggested that the lack of efficacy of ICI treatment in cancers expressing mutant forms of the EGFR may not depend on an enhanced expansion of Treg populations in EGFR overexpressing tumours. The gene discussed is EGFR; the disease is cancer.